Abstract

Fosfomycin (FOS) is an antibiotic used in pig farms for treatment and prevention of infections caused by resistant bacteria during the post-weaning period. Antibiotics and non-toxic concentrations of mycotoxins, such as deoxynivalenol (DON) are frequently found in the diet of animals. These compounds can establish interactions in the intestinal tract, which could affect and/or modify the penetration of FOS to enterocytes. The aim of this study was to determine the penetration of FOS into IPECJ-2 cells, a cell line derived from the small intestine of piglets, in the presence and absence of DON. The results from this study showed that there was statistically significant difference in the intracellular concentration of FOS between cells incubated with 580 µg/ml FOS and cells incubated with 580 µg/ml FOS and 1 µg/ml DON. The Cmax of the intracellular antibiotic in the culture plates incubated with FOS in absence of DON was 45.81 µg/ml with a tmax of 4 h. When IPEC-2 cells were incubated with FOS and DON the Cmax was 20.06 µg/ml and the tmax was 30 min. It is concluded that the non-toxic concentration of DON on IPEC-J2 cells after short-term exposure, interferes with the pharmacokinetics of the antibiotic.

Highlights

  • Fosfomycin (FOS), cis-1,2-epoxyphosphonic acid, is an antibacterial drug discovered in 1961

  • An important function of the gastrointestinal epithelium is to provide a barrier against the penetration of food contaminants and pathogens present in the intestinal lumen [30]

  • We demonstrated that the intracellular concentration of FOS in IPEC-J2 cells decreased in the presence of low concentrations of DON

Read more

Summary

Introduction

Fosfomycin (FOS), cis-1,2-epoxyphosphonic acid, is an antibacterial drug discovered in 1961 It has a low molecular weight (138.059 Da) and its chemical structure is similar to that of phosphoenol-pyruvate. Two symmetrical phosphate radicals, connected to a three carbon structure give this drug a unique chemical structure unrelated to other antibacterial families and no cross-resistance with other antibiotics has been reported [1,2]. It has a wide spectrum antibacterial activity against grampositive and gram-negative bacteria [3,4,5,6].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call